生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Tyrphostin AG30 (AG30) is a potent and selective EGFR tyrosine kinase inhibitor. The c-ErbB-specific tyrphostin AG30 specifically blocked STAT5 activation, implicating this signal transducer in c-ErbB-induced self renewal[1]. Treatment of human colon cancer cell lines, LS 174T, COLO 205, and SW620, with sodium butyrate and 8-Cl-cAMP or tyrphostins AG-30 and AG-34, significantly attenuated TPK (tyrosine protein kinase) activity concomitantly with an increase in the activity of alkaline phosphatase, an enzymatic marker of intestinal cell differentiation. The induction of the differentiated phenotype in colon cancer cells is associated with a marked decrease in TPK activity and tyrosine phosphorylation[2]. Preincubation of B lymphocytes with two different tyrphostins blocked anti-IgM-induced tyrosine phosphorylation and actin polymerization[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.87mL 0.97mL 0.49mL |
24.37mL 4.87mL 2.44mL |
48.74mL 9.75mL 4.87mL |
参考文献 |
---|